Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interfering with hepatitis C virus RNA replication.

Glenn Randall1, Charles M Rice

  • 1Laboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, Box 64, New York, NY 10021, USA.

Virus Research
|April 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same author

A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization.

bioRxiv : the preprint server for biology·2026
Same author

Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse models.

Science advances·2026
Same author

Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.

Journal of human immunity·2026
Same author

Factor VIII originates primarily from anatomically distinct subsets of liver sinusoidal endothelial cells.

Blood advances·2026
Same journal

Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically.

Virus research·2026
Same journal

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo.

Virus research·2026
Same journal

Case report: A case of HIV seroconversion in a high-risk individual after 35 years of resistance with a CCR5Δ32 heterozygous genotype.

Virus research·2026
Same journal

Viruses under mechanical force: Implications and applications.

Virus research·2026
Same journal

Mechanisms and therapeutic implications of galectins regulating Epstein-Barr virus infection.

Virus research·2026
Same journal

Functional SLC29A3/ENT3 drives autophagic clearance of intracellular viral particles.

Virus research·2026
See all related articles

RNA interference (RNAi) uses small interfering RNAs (siRNAs) to silence gene expression, offering a tool to study hepatitis C virus (HCV) replication. While effective in experiments, therapeutic applications face challenges.

Area of Science:

  • Molecular Biology
  • Virology
  • Genetics

Background:

  • RNA interference (RNAi) is a natural gene silencing process.
  • Small interfering RNAs (siRNAs) are key effectors of RNAi.
  • RNAi has shown potential in modulating gene expression.

Purpose of the Study:

  • To explore the use of RNA interference (RNAi) for studying hepatitis C virus (HCV) gene expression and replication.
  • To investigate the potential of RNAi as an antiviral therapy against HCV.

Main Methods:

  • Introduction of small interfering RNAs (siRNAs) into mammalian cells.
  • Monitoring the degradation of homologous messenger RNAs (mRNAs).
  • Assessing the impact of siRNAs on viral gene expression and replication.

Related Experiment Videos

Main Results:

  • siRNAs efficiently silence both cellular and viral gene expression.
  • siRNAs were shown to interfere with hepatitis C virus (HCV) gene expression and replication.
  • HCV replication led to the silencing of cellular genes.

Conclusions:

  • RNA interference (RNAi) serves as a valuable experimental tool for dissecting HCV replication mechanisms.
  • RNAi can identify host genes critical for viral replication.
  • The therapeutic application of RNAi for HCV faces significant hurdles common to nucleic acid-based therapies.